What: Combined Medical Device & Biotechnology Partnership Meeting
When: June 2, 2015 –June 3, 2015
Where: USPTO Campus, Madison North Auditorium
600 Dulany Street
Alexandria, VA 22314
The United States Patent and Trademark Office (“USPTO”) periodically hosts “Medical Device Technology Partnership Meetings” to bring those working in the medical device industry and USPTO personnel together to share their ideas and experiences. The aim of the meetings is to help the USPTO develop medical device best patent prosecution practices and to provide a sounding board as to how the USPTO can improve and expand its relationship with the medical device technology community.
Past topics have included the America Invents Act (AIA), examiner interview best practices, “means-plus-function” claim guidelines, and new Board of Appeals rules and pre-appeal/appeal conferences.
The next Medical Device Technology Partnership Meeting will be held on Tuesday, June 2 and Wednesday June 3, 2015. According to the USPTO’s notice, the June meetings will include officials from Technology Unit 3700, as well as Mr. Rick Seidel, who is the Assistant Deputy Commissioner for Patents, Mechanical Disciplines at the USPTO. Unless there is a change before the meeting, currently the following officials from Tech Unit 3700 will attend:
- Angela Sykes, Group Director TC 3700, USPTO
- Donald Hajec, Group Director TC 3700, USPTO
- Andrew Wang, Group Director TC 3700, USPTO
- Diego Gutierrez, Group Director TC 3700, USPTO
Per the USPTO’s notice, space is limited and registration will be done on a first-come first-served basis. To RSVP, visit the Combined Medical Device & Biotechnology Partnership Meeting registration page.
Unfortunately, we didn’t see that there is a virtual option to attend the meeting online, but we’re currently checking this with the USPTO. If you’re in the D.C. area and attend, we’d love to hear your thoughts on the USPTO’s Medical Device Partnership and whether you believe that it is helping issues related to medical device patent prosecution.